(Q64604751)
Statements
AFF008A (English)
0 references
Phase IB Follow-up, Randomized, Controlled, Parallel Group, Patient-blinded, Single-center Study to Assess One Boost With AFFITOPE® PD01A With Regard to Safety/Tolerability, Immunological + Clinical Activity in Patients Who Have Received the Vaccine Within the Study AFF008 (English)
0 references
August 2014
0 references
August 2015
0 references
28
0 references
40 year
0 references
68 year
0 references